It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Host genetic susceptibility to leprosy has been intensively investigated over the last decades; however, there are no studies on the role of genetic variants in disease recurrence. A previous initiative identified three recurrent cases of leprosy for which none of the M. leprae strains, as obtained in the first and the second diagnosis, had any known genomic variants associated to resistance to Multidrug therapy; in addition, whole genome sequencing indicated that the same M. leprae was causing two out of the three recurrences. Thus, these individuals were suspected of being particularly susceptible to M. leprae infection, either as relapse or reinfection. To verify this hypothesis, 19 genetic markers distributed across 11 loci (14 genes) classically associated with leprosy were genotyped in the recurrent and in three matching non-recurrent leprosy cases. An enrichment of risk alleles was observed in the recurrent cases, suggesting the existence of a particularly high susceptibility genetic profile among leprosy patients predisposing to disease recurrence.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Graduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Rua Imaculada Conceição 1155 - Prado Velho, Paraná, Brazil (GRID:grid.412522.2) (ISNI:0000 0000 8601 0541)
2 Tropical Medicine Centre, University of Brasília, UnB - Brasília, Brazil (GRID:grid.7632.0) (ISNI:0000 0001 2238 5157); Campus Universitário Darcy Ribeiro, S/N, Asa Norte, Brasília - DF, Brasil (GRID:grid.7632.0) (ISNI:0000 0001 2238 5157); Escola Fiocruz de Governo, Fiocruz Brasília, Avenida L3 Norte, s/n, Campus Universitário Darcy Ribeiro, Gleba A, Brazil (GRID:grid.7632.0) (ISNI:0000 0001 2238 5157)
3 Tropical Pathology and Public Health Institute, Federal University of Goiás, Rua 235 - s/n - Setor Universitário - Goiania, Goiania, Brazil (GRID:grid.411195.9) (ISNI:0000 0001 2192 5801)
4 Dona Libânia Dermatology Centre, R. Pedro I, 1033 - Centro, Fortaleza, Brazil (GRID:grid.411195.9)
5 Tropical Dermatology and Venerology, Fundação Alfredo da Matta, Av. Codajás, 24 - Cachoeirinha, Manaus, Brazil (GRID:grid.411195.9)
6 Lauro Souza Lima Institute, Rodovia Comandante João Ribeiro de Barros, km 225/226, s/n - Distrito Industrial Marcus Vinícius Feliz Machado, Bauru, Brazil (GRID:grid.411195.9)
7 Epidemiology and Biostatistics Department, Universidade Federal Fluminense, Rua Marquês do Paraná, 303, Centro, Niterói, Brazil (GRID:grid.411173.1) (ISNI:0000 0001 2184 6919)
8 Infectious Diseases and Immunity in Global Health (IDIGH) Program at the Research Institute of the McGill University Health Centre (RI-MUHC), 1001 Boulevard Décarie, Bioinformatics suite ES1.5561, H4A 3J1., Montreal, Canada (GRID:grid.411173.1)
9 Escola Fiocruz de Governo, Fiocruz Brasília, Avenida L3 Norte, s/n, Campus Universitário Darcy Ribeiro, Gleba A, Brazil (GRID:grid.7632.0) (ISNI:0000 0001 2238 5157)